News
NCCS and tech firm to collaborate on Asian-prevalent cancer research
NCCS and tech firm to collaborate on Asian-prevalent cancer research
The deal will speed up translational cancer research over the next two years.
India gears up for Nipah virus outbreak
Five more samples tested negative for the virus.
China’s anti-corruption campaign to have a long-term positive outlook for healthcare
It will encourage healthcare firms to adopt strict rules for future procurement.
South Korea and Africa discuss global healthcare workforce
Other discussions include vaccine and biotechnology cooperation.
Philippine gov’t OKs law putting up speciality health centers
The health centres will prioritise cancer and cardiovascular care, amongst others.
Smart hospital beds market’s CAGR to grow 14% from 2022 to 2030
Its revenue is seen to reach US$1.49b by 2030.
Bumrungrad and BDMS to benefit from Thai strong medical tourism
The hospitals’ revenues will grow 10% over the next five years.
Healthcare businesses urged to address these five AI risks
Amongst the risks are bias, misinformation, and privacy.
India to account for 18% of APAC's surgical sutures market
GlobalData finds risks in traditional suturing techniques for India.
Outlook uncertain for India’s generic drug makers: Fitch
The country is expected to retain its position as ‘pharmacy of the world’ despite challenges.
Singapore’s National University Cancer Institute welcomes new director
The outgoing director is exiting after nine years of service
SG medical device market to generate a CAGR of 7.4% from 2022-2027
The market will reach $1.4b (USD1.1b) by 2027.
New Primary Care Research Institute to boost SingHealth Polyclinics
The SingHealth Polyclinics and its partners will explore new models of primary care.
Supercomputer deployed for AI tool needs in NUHS
The Prescience supercomputer will train AI models that will enhance treatments.
IHH net income down 51% YoY in Q2
The decline was driven by foreign exchange losses amidst Turkish Lira devaluation.
IHH SG boss appointed as Group CEO
Dr. Prem Kumar Nair was chosen due to his strong credentials.
HK health secretary discussing collab with Mainland on transplantation
They are looking into exploring academic exchanges and organ transplant.
Most Read
1. Asian medical device markets face cost shocks amidst Iran conflict 2. Gene and cell therapy boom drives DNA manufacturing market toward $21.82B by 2034 3. Global dental articulators market to reach $227.8m by 2030 4. HSA to expand role in accelerating biomedical sector growth: Ong Ye Kung 5. AJJ Medtech hits $8m order book with $3m green supply dealResource Center
Read Here
Advertise
Sign Up
Events
Event News
He discusses how healthcare systems in Asia Pacific need to evolve beyond simply expanding coverage and towards delivering equitable, sustainable, and high-impact care.
Commentary
Beyond ChatGPT: The rise of multimodal AI assistants in clinical settings
2026 biotech playbook: Hong Kong at the centre of China’s globalisation